Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2023

Open Access 03-02-2023 | Metastasis | ASO Author Reflections

ASO Author Reflections: Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis

Authors: T. J. Weijs, MD, PhD, S. van der Horst, MSc, R. van Hillegersberg, MD, PhD

Published in: Annals of Surgical Oncology | Issue 5/2023

Login to get access

Excerpt

Esophageal cancer remains a devastating disease, of which the incidence is increasing.1 The cornerstone of treatment with curative intent is surgical resection. However, in case of preoperatively confirmed lymph node metastasis to the neck, patients are generally precluded surgery. The concurrent palliative treatment approach is associated with a limited 1 year survival of 32–39%. An alternative treatment approach would be neoadjuvant chemoradiotherapy followed by robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy, including the cervical lymph nodes. Whether this would be feasible and safe for the Western population was unclear up to now. …
Literature
2.
go back to reference van der Horst S, Weijs TJ, Braunius WW, et al. Safety and feasibility of Robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy and neoadjuvant chemoradiotherapy in patients with resectable esophageal cancer and cervical lymph node metastasis. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-022-12996-x.CrossRefPubMed van der Horst S, Weijs TJ, Braunius WW, et al. Safety and feasibility of Robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy and neoadjuvant chemoradiotherapy in patients with resectable esophageal cancer and cervical lymph node metastasis. Ann Surg Oncol. 2023. https://​doi.​org/​10.​1245/​s10434-022-12996-x.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis
Authors
T. J. Weijs, MD, PhD
S. van der Horst, MSc
R. van Hillegersberg, MD, PhD
Publication date
03-02-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 5/2023
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-13137-8

Other articles of this Issue 5/2023

Annals of Surgical Oncology 5/2023 Go to the issue